Immediate Impact

1 by Nobel laureates 1 from Science/Nature 57 standout
Sub-graph 1 of 24

Citing Papers

mRNA vaccines for infectious diseases — advances, challenges and opportunities
2024 Standout
ESKAPE pathogens: antimicrobial resistance, epidemiology, clinical impact and therapeutics
2024 Standout
2 intermediate papers

Works of Shon Remich being referenced

A Phase 2 Study Evaluating the Safety, Tolerability, and Immunogenicity of Two 3-Dose Regimens of a Clostridium difficile Vaccine in Healthy US Adults Aged 65 to 85 Years
2019
Evaluation of RTS,S/AS02A and RTS,S/AS01B in Adults in a High Malaria Transmission Area
2009

Author Peers

Author Last Decade Papers Cites
Shon Remich 183 78 19 56 11 284
Irene N. Nkumama 163 44 14 35 10 240
James Campbell 192 92 9 46 19 324
Sachy Orr-Gonzalez 179 38 20 21 16 243
Vera von Kalckreuth 167 47 15 30 18 239
Irene Handayuni 255 30 7 22 16 312
Ulysse Ateba-Ngoa 162 47 13 35 13 330
Wynand Smythe 135 118 11 117 9 303
Youssouf Tolo 255 42 16 30 16 317
Joseph F. Abdallah 271 42 15 44 10 311
David Padley 204 77 6 65 9 318

All Works

Loading papers...

Rankless by CCL
2026